Julie Diboll
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Autoreactivity Versus Autoimmunity: Characteristics of Autoantigen-Specific CD4 T Cells in Rheumatoid Arthritis and Health.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 06, 2025
Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis.
Journal: Trials
Published: March 13, 2025
Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis.
Journal: Annals of the rheumatic diseases
Published: February 13, 2025
In Vitro Generation of Human Tolerogenic Monocyte-Derived Dendritic Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 27, 2023
Fluorine labelling of therapeutic human tolerogenic dendritic cells for 19F-magnetic resonance imaging.
Journal: Frontiers in immunology
Published: July 07, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
Journal: Annals of the rheumatic diseases
Published: February 16, 2022
Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease loci.
Journal: The Journal of allergy and clinical immunology
Published: April 10, 2019
Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis.
Journal: Rheumatology (Oxford, England)
Published: June 21, 2018
CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Patients With Untreated Early Arthritis: Implications for Causal Gene Identification.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 02, 2017
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies.
Journal: Arthritis research & therapy
Published: August 18, 2016
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies.
Journal: PeerJ
Published: June 16, 2016
Last Updated: 09/26/2026